Otsuka Pharmaceutical Companies (U.S.) | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Otsuka Pharmaceutical Companies (U.S.) is part of Otsuka Holdings Co., Ltd., a global healthcare group encompassing over 180 companies and more than 45,000 employees worldwide. Its U.S. operations include Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc., which are dedicated to pharmaceutical research, development, commercialization, and medical device activities.

With roots dating back to Japan in 1921 and an expansion into the U.S. in 1985, the organization develops and markets innovative products spanning central nervous system disorders, oncology, gastroenterology, ophthalmology, and cardiovascular health. It also pioneers medical device innovations including vascular stents and ultrasound renal denervation systems. Otsuka supports patients with resource programs and assistance focused on improving health and well-being, reflecting a mission to enhance global health through creativity and innovation.